The effects of tricyclic antidepressants on breast cancer risk.
about
Paroxetine-The Antidepressant from Hell? Probably Not, But Caution RequiredAntidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industryA population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsTesting whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer.Colorectal cancer risk in relation to antidepressant medication use.Antidepressants and the risk of breast cancer.Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates.Breast cancer recurrence risk in relation to antidepressant use after diagnosis.Review of the epidemiological literature on antidepressant use and breast cancer risk.Use of antidepressant medications in relation to the incidence of breast cancer.Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies.Efficient sampling approaches to address confounding in database studies.Antidepressant medication use and breast cancer riskThe antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.Associations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancerAntidepressants and risk of prostate cancer: a nested case-control study.Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines.Relationship between antidepressant prescription and breast cancer: a population based study in Taiwan.Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer.In vivo genotoxicity of dental bonding agents.
P2860
Q28069392-1433CD71-D4CE-4864-8E21-BA9F4FC05636Q28477668-82FA5671-7C9B-4998-AC33-6734CC9B7F71Q33777598-1520880F-2F21-4B64-B782-A66E257FE235Q34109699-95D616EC-A1AA-40AE-8AF3-8723792D56C3Q34144147-CDDB164A-D30B-4387-BD36-0BDEB791A8DFQ34234319-9A075C09-442D-4934-AF21-EA3AEC33FF9DQ35054804-D40E40B3-9954-4AC7-A24B-6D5FC62A2095Q36372263-6069AB9E-3B60-4E65-AC4F-5BA52DE42470Q36459134-D37DC7C6-E29F-41BA-93EE-859EEF8AFB88Q36607352-CD22CFB3-B751-49C5-B784-B7C795008838Q36614001-D549B05A-13C4-49FC-AAAD-A5E0A9A16CE9Q36998348-3BCB7077-44D7-496C-A3AD-3F90EF32B46DQ37278735-40FC2D1A-61E4-4551-9EC2-F95BED585D70Q37289045-869BE1AD-7E7D-4D00-B2BE-184D7D5C86B3Q37389659-A8C8C100-2D6A-4F3F-90FE-E9867EFC6359Q37456883-7C523820-D49D-4BFE-8C1B-C80A36694303Q38461414-5D85017D-3465-4EE0-A77E-99F2890DF67FQ40624936-11FA428D-9B7D-41F2-AC35-1F570BD76ABBQ41482538-6633F960-09C9-4268-B2AB-501FBE988787Q41773306-AAF7072B-C2C3-45E4-96A4-5E7E015D5A01Q46220301-4D10FD8D-32DF-4F07-9426-A56144AAE0B7
P2860
The effects of tricyclic antidepressants on breast cancer risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effects of tricyclic antidepressants on breast cancer risk.
@en
The effects of tricyclic antidepressants on breast cancer risk.
@nl
type
label
The effects of tricyclic antidepressants on breast cancer risk.
@en
The effects of tricyclic antidepressants on breast cancer risk.
@nl
prefLabel
The effects of tricyclic antidepressants on breast cancer risk.
@en
The effects of tricyclic antidepressants on breast cancer risk.
@nl
P2093
P2860
P356
P1476
The effects of tricyclic antidepressants on breast cancer risk.
@en
P2093
C R Sharpe
J A Hanley
J-F Boivin
J-P Collet
P2860
P2888
P356
10.1038/SJ.BJC.6600013
P407
P577
2002-01-01T00:00:00Z